Lederer & Associates Investment Counsel’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.83M Sell
11,162
-197
-2% -$45.9K 1.87% 12
2026
Q1
$2.78M Sell
11,359
-1,897
-14% -$442K 1.97% 10
2025
Q4
$2.74M Sell
13,256
-28
-0.2% -$5.54K 1.84% 12
2025
Q3
$2.46M Sell
13,284
-406
-3% -$69.6K 1.6% 14
2025
Q2
$2.09M Sell
13,690
-580
-4% -$89.2K 1.38% 19
2025
Q1
$2.37M Buy
14,270
+105
+0.7% +$16.4K 1.73% 12
2024
Q4
$2.05M Buy
14,165
+26
+0.2% +$4.03K 1.43% 16
2024
Q3
$2.29M Sell
14,139
-142
-1% -$22.6K 1.61% 13
2024
Q2
$2.09M Sell
14,281
-1,490
-9% -$222K 1.51% 17
2024
Q1
$2.5M Sell
15,771
-51
-0.3% -$8.12K 1.73% 13
2023
Q4
$2.48M Sell
15,822
-120
-0.8% -$18.4K 1.84% 13
2023
Q3
$2.48M Sell
15,942
-341
-2% -$56.3K 1.97% 11
2023
Q2
$2.69M Sell
16,283
-137
-0.8% -$22.1K 2.03% 10
2023
Q1
$2.54M Sell
16,420
-101
-0.6% -$16.3K 1.96% 8
2022
Q4
$2.92M Sell
16,521
-331
-2% -$57.2K 2.39% 5
2022
Q3
$2.75M Sell
16,852
-224
-1% -$37.9K 2.33% 7
2022
Q2
$3.03M Sell
17,076
-2,142
-11% -$382K 2.34% 7
2022
Q1
$3.41M Sell
19,218
-185
-1% -$31.5K 2.09% 8
2021
Q4
$3.32M Buy
19,403
+9
+0% +$1.47K 1.92% 11
2021
Q3
$3.13M Buy
19,394
+167
+0.9% +$28.5K 2.02% 11
2021
Q2
$3.17M Sell
19,227
-424
-2% -$70.2K 2.11% 12
2021
Q1
$3.23M Buy
19,651
+292
+2% +$47.2K 2.28% 6
2020
Q4
$3.05M Sell
19,359
-95
-0.5% -$14K 2.34% 7
2020
Q3
$2.9M Buy
19,454
+324
+2% +$47.9K 2.41% 6
2020
Q2
$2.69M Buy
19,130
+38
+0.2% +$5.54K 2.51% 7
2020
Q1
$2.5M Sell
19,092
-1,062
-5% -$151K 2.83% 5
2019
Q4
$2.94M Buy
20,154
+129
+0.6% +$17.5K 2.55% 5
2019
Q3
$2.59M Buy
20,025
+210
+1% +$27.7K 2.48% 6
2019
Q2
$2.76M Buy
19,815
+55
+0.3% +$7.61K 2.53% 5
2019
Q1
$2.76M Buy
19,760
+25
+0.1% +$3.35K 2.57% 5
2018
Q4
$2.55M Buy
19,735
+1,725
+10% +$241K 2.72% 3
2018
Q3
$2.49M Buy
18,010
+645
+4% +$85.7K 2.1% 11
2018
Q2
$2.11M Sell
17,365
-120
-0.7% -$15K 1.9% 15
2018
Q1
$2.24M Sell
17,485
-210
-1% -$28.4K 2.02% 11
2017
Q4
$2.47M Sell
17,695
-2,492
-12% -$347K 2.21% 9
2017
Q3
$2.63M Buy
20,187
+120
+0.6% +$15.9K 2.5% 6
2017
Q2
$2.65M Buy
20,067
+1,225
+7% +$156K 2.56% 4
2017
Q1
$2.35M Buy
18,842
+25
+0.1% +$2.99K 2.2% 7
2016
Q4
$2.17M Buy
+18,817
New +$2.17M 2.15% 9
2015
Q3
$1.79M Sell
19,144
-206
-1% -$19.9K 1.99% 17
2015
Q2
$1.89M Buy
19,350
+385
+2% +$38.6K 1.94% 17
2015
Q1
$1.91M Buy
18,965
+710
+4% +$72.2K 1.86% 18
2014
Q4
$1.91M Buy
+18,255
New +$1.92M 1.89% 20

Other funds holding JNJ

Lederer & Associates Investment Counsel's JNJ Position: Q2 2026 in Review

Lederer & Associates Investment Counsel reduced its Johnson & Johnson (JNJ) stake by 1.7% in Q2 2026, selling an estimated $45.9K and leaving 11,162 shares worth $2.83M. The position accounts for 1.87% of the portfolio, ranked #12.

Lederer & Associates Investment Counsel first reported a position in JNJ in Q4 2014 and has held it in 43 quarters since. The position peaked at $3.41M in Q1 2022. 2,235 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Lederer & Associates Investment Counsel held 11,162 shares of Johnson & Johnson worth $2.83M as of Q2 2026.
  • Lederer & Associates Investment Counsel sold 197 Johnson & Johnson shares in Q2 2026, an estimated $45.9K.
  • Johnson & Johnson made up 1.87% of Lederer & Associates Investment Counsel's portfolio in Q2 2026, its #12 holding.
  • Lederer & Associates Investment Counsel first reported a position in Johnson & Johnson in Q4 2014 and has held it in 43 quarters since.
  • Lederer & Associates Investment Counsel's Johnson & Johnson position peaked at $3.41M in Q1 2022.
  • 2,235 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Lederer & Associates Investment Counsel's 13F filing for Q2 2026, filed 10 Jul 2026.